Saliva-Based Biomarkers for Non-Invasive Assessment of Pediatric Gastrointestinal Inflammatory Diseases: Current Evidence and Future Perspectives

Background/Objectives: Endoscopy with biopsy remains central to the diagnosis and assessment of pediatric inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), and celiac disease (CD). However, its invasive nature, procedural burden, cost, and limited suitability for repeated assessment highlight the need for non-invasive biomarkers in children. This review critically evaluates the current evidence for saliva-based biomarkers in these disorders. Methods: A critical narrative literature search was performed in PubMed/MEDLINE and Scopus to identify studies on salivary biomarkers in pediatric IBD, EoE, and CD. Pediatric evidence was prioritized; adult studies were included only when pediatric data were unavailable or limited, and were explicitly distinguished from pediatric findings. Results: Saliva offers major practical advantages in children because collection is painless, inexpensive, repeatable, and feasible without venipuncture or sedation. However, salivary profiles are influenced by oral health, diet, collection procedures, and other pre-analytical factors. In IBD, pediatric evidence remains limited and heterogeneous, with preliminary signals from salivary calprotectin, microbiome, and high-dimensional proteomics. In EoE, salivary microRNAs, volatile organic compounds, and selected microbial taxa show promising but exploratory results, mainly in small cohorts. In CD, salivary anti-tissue transglutaminase IgA has the most interesting pediatric evidence, including data from population-based screening studies. Conclusions: Saliva cannot currently replace established diagnostic tools. The level of evidence varies substantially across diseases: salivary anti-tTG IgA has the most substantial paediatric evidence and may have a complementary role in population-based screening, whereas findings in IBD and EoE remain largely exploratory. Future studies should prioritise methodological standardisation, prospective multicentre validation and direct comparisons with established diagnostic and monitoring standards.

Authors

Institutions

Publication Details

Journal
Children
Published
2026-11-19
DOI
https://doi.org/10.3390/children13111608
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Saliva-Based Biomarkers for Non-Invasive Assessment of Pediatric Gastrointestinal Inflammatory Diseases: Current Evidence and Future Perspectives

Naire Sansotta, Lorenzo D’Antiga, Silvia Salvatore, Andrea Scavella
Children
Inflammatory Bowel Disease
article

Saliva-Based Biomarkers for Non-Invasive Assessment of Pediatric Gastrointestinal Inflammatory Diseases: Current Evidence and Future Perspectives

Naire Sansotta, Lorenzo D’Antiga, Silvia Salvatore, Andrea Scavella
article en

Abstract

Background/Objectives: Endoscopy with biopsy remains central to the diagnosis and assessment of pediatric inflammatory bowel disease (IBD), eosinophilic esophagitis (EoE), and celiac disease (CD). However, its invasive nature, procedural burden, cost, and limited suitability for repeated assessment highlight the need for non-invasive biomarkers in children. This review critically evaluates the current evidence for saliva-based biomarkers in these disorders. Methods: A critical narrative literature search was performed in PubMed/MEDLINE and Scopus to identify studies on salivary biomarkers in pediatric IBD, EoE, and CD. Pediatric evidence was prioritized; adult studies were included only when pediatric data were unavailable or limited, and were explicitly distinguished from pediatric findings. Results: Saliva offers major practical advantages in children because collection is painless, inexpensive, repeatable, and feasible without venipuncture or sedation. However, salivary profiles are influenced by oral health, diet, collection procedures, and other pre-analytical factors. In IBD, pediatric evidence remains limited and heterogeneous, with preliminary signals from salivary calprotectin, microbiome, and high-dimensional proteomics. In EoE, salivary microRNAs, volatile organic compounds, and selected microbial taxa show promising but exploratory results, mainly in small cohorts. In CD, salivary anti-tissue transglutaminase IgA has the most interesting pediatric evidence, including data from population-based screening studies. Conclusions: Saliva cannot currently replace established diagnostic tools. The level of evidence varies substantially across diseases: salivary anti-tTG IgA has the most substantial paediatric evidence and may have a complementary role in population-based screening, whereas findings in IBD and EoE remain largely exploratory. Future studies should prioritise methodological standardisation, prospective multicentre validation and direct comparisons with established diagnostic and monitoring standards.

ChildrenVol. 13(11)
University of Insubria (IT), Ospedale Filippo Del Ponte Varese (IT), Ospedale Papa Giovanni XXIII (IT), University of Milano-Bicocca (IT)
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon